Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
International Journal of Cancer|August 9, 1995
Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE)J M Bliss, D Ford, A J Swerdlow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer GroupR C Coombes, P S Schein, C E Chilvers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Epirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer GroupJ A Wils, J M Bliss, M Marty, et al.British Journal of Cancer|October 9, 1998
Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patientsM Shayeghi, S Seal, J Regan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2010
A randomised comparative trial of infusional ECisF versus conventional FEC as adjuvant chemotherapy in early breast cancer: the TRAFIC trialB Sirohi, R A'Hern, G Coombes, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2005
High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trialR C Coombes, A Howell, M Emson, et al.Breast Cancer Research and Treatment|February 13, 2014
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancerS Irshad, C Gillett, S E Pinder, et al.British Journal of Cancer|October 13, 2011
Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?R Leonard, R Ballinger, D Cameron, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2020
Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trialO Sipos, H Tovey, J Quist, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2005
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2)S Chua, I E Smith, R P A'Hern, et al.Pageof 7